⌘K

Login Start Free

Home/Filings/4/0001209191-19-000970

4//SEC Filing

Slover Peter T 4

Accession 0001209191-19-000970

CIK 0001563855other

View on SEC.gov Company Profile

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 4:28 PM ET

Size

5.3 KB

Accession

0001209191-19-000970

Insider Transaction Report

Form 4

Period: 2018-12-31

SOPHIRIS BIO INC.SPHS

Chief Financial Officer

Transactions

Award
Common Stock (Right to Buy)
2018-12-31+205,667→ 205,667 total
Exercise: $0.83From: 2019-12-21Exp: 2028-12-30→ Common Stock (205,667 underlying)

Footnotes (1)

[F1]33% of the shares subject to the option shall vest on December 21, 2019. The remainder shall vest monthly thereafter over the next two years until fully vested on December 21, 2021.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

SOPHIRIS BIO INC.

CIK 0001563855

Entity typeother

Related Parties

1

filerCIK 0001468012

Filing Metadata

Form type: 4
Filed: Jan 2, 7:00 PM ET
Accepted: Jan 3, 4:28 PM ET
Size: 5.3 KB

View on SEC.gov